XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Warrants
The following table represents a summary of warrants for the nine months ended September 30, 2025 and the year ended December 31, 2024:
Nine Months Ended
September 30, 2025
Year Ended
December 31, 2024
NumberWeighted
Average
Exercise
Price
NumberWeighted
Average
Exercise
Price
Beginning balance8,744,698$1.40 7,444,698$1.68 
Granted8,666,6671.15 11,631,0350.34 
Exercised(8,509,926)0.83 (10,331,035)0.41 
Expired(3,247,458)1.08 — — 
Ending balance5,653,981$2.05 8,744,698$1.40 
Warrants exercisable 5,653,9818,744,698
Intrinsic value of warrants$53,293 $6,661,661 
Weighted Average Remaining Contractual Life (Years)3.373.86
Schedule of Options
The following represents a summary of options for the Second Amended Plan and additional options granted outside of the Second Amended Plan, for the nine months ended September 30, 2025 and the year ended December 31, 2024:
NumberWeighted
Average
Exercise
Price
Weighted-Average Remaining Contractual Term (in Years)Weighted
Average
Fair Value
Outstanding December 31, 20249,515,000 $2.03 3.89$3.12 
Granted1,855,0001.076.301.05
Exercised(250,000)0.2100.19
Forfeited(687,500)0.802.00
Outstanding September 30, 202510,432,500$1.99 4.08$2.82 
As of September 30, 2025
Vested and exercisable7,601,835$2.09 4.31$2.47 
Schedule of Stock Options, Valuation Assumptions The following assumptions were used for the periods as follows:
Nine Months Ended
September 30, 2025
Year
Ended
December 31, 2024
Expected term7 years7 years
Expected volatility
164.63% – 169.72%
123.05% – 124.33%
Expected dividend yield— — 
Risk-free interest rate
4.14% – 4.51%
3.89% - 4.45%